Picture of Basilea Pharmaceutica AG, Allschwil logo

BSLN — Basilea Pharmaceutica AG, Allschwil News Story

0.000.00%
ch flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Swiss stocks - Factors to watch on September 7

ZURICH/BERLIN, Sept 7 (Reuters) - Here are some of the main
factors that may affect Swiss stocks on Wednesday:
    
    RICHEMONT  CFR.S  
    The luxury goods group is due to hold its annual general
meeting in Geneva. Shareholders will get to vote on requests
submitted by activist investor Bluebell.  CFR.S 
    
    ABB ABBN.S  
    The Swiss automation group holds its annual general meeting.
 ABBN.S 
    
    COMPANY STATEMENTS
    Basilea  BSLN.S  announces Chf 75 Million senior secured
loan agreement with Athyrium for non-dilutive refinancing of
convertible bonds due in December.  BSLN.S 
    Holcim  HOLN.S  said it closed the sale of its business in
Brazil to CSN for an enterprise value of $1.025 bln.  HOLN.S 
    
    ANALYSTS' VIEWS
    BELIMO HOLDING AG  BEAN.S  CREDIT SUISSE CUTS TARGET PRICE
TO CHF 335 FROM CHF 411
    U BLOX HOLDING AG  UBXN.S : CREDIT SUISSE RAISES TARGET
PRICE TO CHF 135 FROM CHF 92
    POLYPEPTIDE GROUP AG  PPGN.S : CREDIT SUISSE CUTS TARGET
PRICE TO CHF 42 FROM CHF 66
    
    ECONOMY
    Swiss August Forex Reserves due at 0700 GMT. 


 (Reporting by Zurich newsroom and Berlin Speed Desk)
 ((+41 58 306 7336; zurich.newsroom@thomsonreuters.com))
 
((For Top News in a multimedia Web format on Eikon visit: https://bit.ly/2NDFd6g
FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:
Daily Swiss stock market report in German  .SDE 
All SMI constituent stocks  0#.SSMI 
DJ STOXX index  .STOXX 
Top 10 STOXX sectors  .PGL.STOXXS 
Top 10 EUROSTOXX sectors  .PGL.STOXXES 
Swiss mid-cap index  .SSMI 
Swiss all-share index  .SSHI 
Swiss market digest  .AD.S 
Sector overview  CH/SECTOR1 
All Swiss news  CH 
Swiss research news  CH-RCH   
All equity news  E 
SPEED GUIDES:   EQUITY   EQUITY/NEWS1   EUR/EQUITY   SWITZERLAND   REUTERS  ))

Recent news on Basilea Pharmaceutica AG, Allschwil

See all news